Heart rate in coronary artery disease: should we lower it?
Kelly Axsom1, Sripal Bangalore
1The Leon H. Charney Division of Cardiology, New York University School of Medicine, New York, NY, 10016, USA.
Insights
Elevated resting heart rate is a risk factor for cardiovascular events. This study explores if selectively lowering heart rate with ivabradine benefits patients with stable coronary artery disease, without heart failure.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Elevated resting heart rate (RHR) is an independent risk factor for cardiovascular morbidity and mortality.
- In coronary artery disease (CAD), high RHR exacerbates myocardial ischemia by reducing diastolic filling time and increasing cardiac workload.
- The prognostic significance of RHR and the efficacy of pharmacological heart rate reduction remain unclear.
Purpose of the Study:
- To investigate the potential benefits of selectively lowering heart rate with ivabradine in patients with stable coronary artery disease without heart failure.
- To differentiate the effects of heart rate reduction from other cardiovascular actions of medications like beta-blockers.
Main Methods:
- Review of existing literature on heart rate, cardiovascular outcomes, and pharmacological interventions.
- Analysis of the mechanism of action of ivabradine, focusing on selective I(f) current inhibition.
- Comparison of ivabradine's effects with those of beta-blockers in cardiovascular patients.
Main Results:
- Ivabradine selectively lowers heart rate by inhibiting the I(f) current, without other significant cardiovascular effects.
- Beta-blockers, while lowering heart rate, also possess other cardiovascular effects, complicating the interpretation of their benefits.
- Early trials suggest promise for ivabradine in heart failure patients.
Conclusions:
- Ivabradine represents a novel therapeutic approach targeting heart rate reduction selectively.
- Further research is needed to establish the efficacy and safety of ivabradine in patients with stable coronary artery disease without heart failure.
- Distinguishing the direct effects of heart rate reduction from other drug-induced effects is crucial for optimizing cardiovascular treatment.
Opinion Statement:
Elevated resting heart rate is an independent risk factor for cardiovascular morbidity and mortality in patients with and without coronary artery disease. In patients with known coronary artery disease, elevated heart rate reduces diastolic filling time and increases cardiac workload, resulting in supply demand mismatch with consequent ischemia and angina. While lower heart rate is associated with better prognosis, it is not known if pharmacological reduction in heart rate is beneficial and if heart rate is merely a marker for increased risk and worse outcomes. Certainly, physiologically lower resting heart rate as attained by exercise improves morbidity and mortality. While physiological reduction in heart rate is mainly a manifestation of increased parasympathetic drive, pharmacological reduction of heart rate with beta-blockers is mediated via the sympathetic pathway and associated with mixed outcomes. In addition, beta-blockers have other cardiovascular effects (lowering blood pressure), are metabolically active, and it is unknown if the beneficial effects (if any) are mediated via reduction in heart rate versus other cardiovascular effects. Ivabradine is a new medication that lowers heart rate selectively by inhibiting the I(f) current without other cardiovascular effects, offering for the first time a therapeutic agent that selectively targets heart rate. The medication has shown promise in early trials in patients with heart failure, but it is unclear if this agent will be beneficial in patients with stable coronary artery disease without heart failure.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with bradycardia...
Coronary Artery Disease I: Introduction
Factors Influencing Heart Rate
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
